Metharbitalum [Inn-Latin] en es it fr

Metharbitalum [Inn-Latin] Brand names, Metharbitalum [Inn-Latin] Analogs

Metharbitalum [Inn-Latin] Brand Names Mixture

  • No information avaliable

Metharbitalum [Inn-Latin] Chemical_Formula


Metharbitalum [Inn-Latin] RX_link

No information avaliable

Metharbitalum [Inn-Latin] fda sheet

Metharbitalum [Inn-Latin] msds (material safety sheet)

Metharbitalum [Inn-Latin] Synthesis Reference

No information avaliable

Metharbitalum [Inn-Latin] Molecular Weight

198.219 g/mol

Metharbitalum [Inn-Latin] Melting Point

150.5 oC

Metharbitalum [Inn-Latin] H2O Solubility

1980 mg/L

Metharbitalum [Inn-Latin] State


Metharbitalum [Inn-Latin] LogP


Metharbitalum [Inn-Latin] Dosage Forms


Metharbitalum [Inn-Latin] Indication

For the treatment of epilepsy

Metharbitalum [Inn-Latin] Pharmacology

Metharbital, a barbiturate, is used for the treatment of short term insomnia. It belongs to a group of medicines called central nervous system (CNS) depressants that induce drowsiness and relieve tension or nervousness. Little analgesia is conferred by barbiturates; their use in the presence of pain may result in excitation.

Metharbitalum [Inn-Latin] Absorption

No information avaliable

Metharbitalum [Inn-Latin] side effects and Toxicity

Signs of overdose include confusion (severe), decrease in or loss of reflexes, drowsiness (severe), fever, irritability (continuing), low body temperature, poor judgment, shortness of breath or slow or troubled breathing, slow heartbeat, slurred speech, staggering, trouble in sleeping, unusual movements of the eyes, weakness (severe).

Metharbitalum [Inn-Latin] Patient Information

No information avaliable

Metharbitalum [Inn-Latin] Organisms Affected

Humans and other mammals